Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptors

Karl Björk1, Anton Terasmaa, Hui Sun

  • 1Laboratory of Clinical and Translational Studies, NIAAA, National Institutes of Health, Bethesda, MD 20892-1108, USA.

Addiction Biology
|May 12, 2010
PubMed

Insights

Ethanol

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Ethanol's reinforcing effects involve opioid and dopaminergic pathways.
  • Intracellular mechanisms mediating these interactions are not well understood.

Purpose of the Study:

  • To investigate the intracellular signaling pathways affected by acute ethanol exposure.
  • To elucidate the roles of opioid and dopamine receptors in ethanol-induced signaling.

Main Methods:

  • Mice were administered acute ethanol.
  • Phosphorylation of AKT and DARPP-32 in the striatum was measured.
  • Effects of opioid receptor antagonist (naltrexone) and dopamine D2 receptor antagonist (sulpiride) were assessed.

Main Results:

  • Acute ethanol increased phosphorylation of AKT and DARPP-32 in the mouse striatum.
  • Ethanol-induced AKT phosphorylation was opioid-dependent but dopamine D2-independent.
  • DARPP-32 phosphorylation was dependent on both opioid and dopamine D2 receptors.

Conclusions:

  • Ethanol engages distinct, potentially synergistic striatal signaling cascades.
  • One cascade is dopamine D2-dependent, while the other is not.
  • The neuropharmacology of ethanol reward is complex and differs from other addictive drugs.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...